In terms of side effects, most users report minimal issues, with occasional mentions of mild digestive discomfort
Innovent presents the results of the first phase 3 study of mazdutide for weight management at the ADAs 84th scientific sessions [Internet]
doi: 10.1073/pnas.0308291101 212 MeyerTEKovcsSJEhsaniAAKleinSHolloszyJOFontanaL
While no significant alterations were observed in biochemical markers, bone density findings suggest localized bone loss at the lumbar spine
"Semaglutide works very well for weight loss," shared Dr
SURMOUNT OSA demonstrated after 52 weeks of treatment, participants who received tirzepatide had greater likelihood of remission or improvement to mild OSA as well as reduced apnea-hypopnea index (AHI) values, hypoxic burden, and systolic blood pressure